Skip to content
Disclosery

KINNEVIK AB (PUBL)

Follow

13F filer, CIK 1766574, STOCKHOLM, Sweden

KINNEVIK AB (PUBL) reported $80,482,316 across 1 holding for the quarter ended 2024-12-31, in a 13F-HR filed 2025-01-23.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-25-005615

Period
2024-12-31
Reported value
$80.5M
Holdings
1
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q4 2024

Share positions as resolved from 13F-HR 0001104659-25-005615, largest first. % of portfolio is the value over $80,482,316, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RXRXRECURSION PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 10,405,668 shares; 2024Q1: 10,405,668 shares; 2024Q2: 11,905,668 shares; 2024Q3: 11,905,668 shares; 2024Q4: 11,905,668 shares 11,905,668$80.5M100%0Timeline

How Q4 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-25-005615 base2025-01-23acceptance time not in the bulk data set